Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients

被引：0
|
作者：
X. Li
W. Qi
R. Yao
D. Tang
J. Liang
机构：
[1] Department of Oncology of the Affiliated Hospital of Medical College Qingdao University,
[2] Central Laboratory of the Affiliated Hospital of Medical College Qingdao University,undefined
[3] Thoracic Surgery of the Affiliated Hospital of Medical College Qingdao University,undefined
来源：
Clinical and Translational Oncology | 2014年 / 16卷
关键词：
FOXM1; Diagnosis; Prognosis; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 314
页数：7
相关论文
共 50 条
  • [1] Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients
    Li, X.
    Qi, W.
    Yao, R.
    Tang, D.
    Liang, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (03): : 307 - 314
  • [2] Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer
    Zhang, Hongmei
    Zhong, Hua
    Li, Lei
    Ji, Wansheng
    Zhang, Xiaoqian
    MOLECULAR MEDICINE REPORTS, 2016, 13 (03) : 2696 - 2700
  • [3] Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
    Li, Xiaoxiao
    Qiu, Wensheng
    Liu, Bin
    Yao, Ruyong
    Liu, Shihai
    Yao, Yasai
    Liang, Jun
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [4] Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
    Xiaoxiao Li
    Wensheng Qiu
    Bin Liu
    Ruyong Yao
    Shihai Liu
    Yasai Yao
    Jun Liang
    Journal of Translational Medicine, 11
  • [5] Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
    Kaoru Okada
    Yoshiyuki Fujiwara
    Tsuyoshi Takahashi
    Yurika Nakamura
    Shuji Takiguchi
    Kiyokazu Nakajima
    Hiroshi Miyata
    Makoto Yamasaki
    Yukinori Kurokawa
    Masaki Mori
    Yuichiro Doki
    Annals of Surgical Oncology, 2013, 20 : 1035 - 1043
  • [6] Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
    Okada, Kaoru
    Fujiwara, Yoshiyuki
    Takahashi, Tsuyoshi
    Nakamura, Yurika
    Takiguchi, Shuji
    Nakajima, Kiyokazu
    Miyata, Hiroshi
    Yamasaki, Makoto
    Kurokawa, Yukinori
    Mori, Masaki
    Doki, Yuichiro
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) : 1035 - 1043
  • [7] Pan-Cancer Upregulation of the FOXM1 Transcription Factor
    Pozzobon, Daniele
    Bellezza, Arianna
    Giorgi, Federico M.
    GENES, 2025, 16 (01)
  • [8] TARGETING FOXM1 TRANSCRIPTION FACTOR IN RHABDOMYOSARCOMA
    Dolan, J. G.
    Wan, X.
    Yeung, C.
    Helman, L. J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (01) : 183 - 183
  • [9] Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
    Li, Qiang
    Zhang, Nu
    Jia, Zhiliang
    Le, Xiangdong
    Dai, Bingbing
    Wei, Daoyan
    Huang, Suyun
    Tan, Dongfeng
    Xie, Keping
    CANCER RESEARCH, 2009, 69 (08) : 3501 - 3509
  • [10] The oncogenic transcription factor FOXM1 and anticancer therapy
    Gartel, Andrei L.
    CELL CYCLE, 2012, 11 (18) : 3341 - +
12345